SCHEMBL1098554

SCHEMBL1098554

COc1cc(CN(c2cc3ccccc3s2)S(=O)(=O)c2ccccc2)ccc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS2R14 Q9NYV8 3/20 0.46
HIF1A Q16665 1/20 0.41
EPAS1 Q99814 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
TRPM8 Q7Z2W7 3/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TSHR P16473 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
HTT P42858 1/20 0.37
MCOLN3 Q8TDD5 1/20 0.37
NAMPT P43490 1/20 0.37
PTGER1 P34995 1/20 0.36
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1099038 0.88 TAS2R14 (0.38) TAS2R14HIF1AEPAS1SMN1; SMN2NAMPT
SCHEMBL1098896 0.87 MEN1 (0.45) TAS2R14HIF1AEPAS1SMN1; SMN2TRPM8
SCHEMBL1098696 0.84 PGR (0.52) TAS2R14TSHRNPSR1KDM4EALDH1A1
SCHEMBL1099770 0.83 SMN1; SMN2 (0.43) TAS2R14HIF1AEPAS1SMN1; SMN2MEN1
SCHEMBL1098903 0.82 TRPM8 (0.56) TRPM8MEN1KMT2AL3MBTL1
SCHEMBL1098229 0.82 PGR (0.53) TAS2R14MEN1KMT2AL3MBTL1TSHR
SCHEMBL1099072 0.82 TAS2R14 (0.46) TAS2R14HIF1AEPAS1SMN1; SMN2MEN1
SCHEMBL1099311 0.81 ALDH1A1 (0.48) SMN1; SMN2TRPM8MEN1KMT2AL3MBTL1
SCHEMBL1099048 0.81 TRPM8 (0.53) TAS2R14HIF1AEPAS1TRPM8NPSR1
SCHEMBL1098989 0.81 MEN1 (0.64) TAS2R14SMN1; SMN2TRPM8MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9434711-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2016-09-06 US disclosed
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-10-23 US disclosed
US-8809327-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2014-08-19 US disclosed
EP-2183239-B1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2012-08-22 EP disclosed
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS BRANUM SHAWN T (US) 2012-07-26 US disclosed
US-8153682-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2012-04-10 US disclosed
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TAS2R14 182/4885HIF1A 1984/4885EPAS1 1697/4885
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TAS2R14 182/4885HIF1A 1984/4885EPAS1 1697/4885
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TAS2R14 182/4885HIF1A 1984/4885EPAS1 1697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.